ARTV Latest Press Releases

-- January 21, 2026 --

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL Globe Newswire 8:00 AM

-- January 8, 2026 --

Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines PRNewswire 3:30 AM

-- November 12, 2025 --

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK in Autoimmune Disease Globe Newswire 7:20 AM

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights Globe Newswire 7:00 AM

-- November 3, 2025 --

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK Globe Newswire 4:05 PM

-- October 30, 2025 --

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November Globe Newswire 4:17 PM

-- October 16, 2025 --

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update Globe Newswire 4:05 PM

-- August 25, 2025 --

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025 Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software